FDA 483 - Mirodx - September 26, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Mirodx, a medical device manufacturer in Dallas, TX, was issued a Form 483 with three observations following an FDA inspection. The firm failed to conduct adequate risk analyses for its Class II VERIS CareKits and exhibited deficiencies in establishing and maintaining records for acceptable suppliers, including missing onsite audits. Additionally, internal quality audits were not conducted by individuals independent of the areas being audited, indicating significant quality system concerns.
ID · 9cc16146-8461-4a30-8594-8089dd87e05a